Cargando…
P-137: COVID – 19 vaccine uptake in patients with multiple myeloma and AL amyloidosis: a crosssectional observational study from India
Autores principales: | Ganju, Prabhat, PK, Jayachandran, Karunakaran, Parathan, V, Surendran, Mehra, Nikita, Kumar, Sathish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403037/ http://dx.doi.org/10.1016/S2152-2650(22)00467-0 |
Ejemplares similares
-
Relevance of flow cytometric categorization and end-of-induction measurable residual disease assessment in pediatric and adult T-lymphoblastic leukemia patients
por: Bommannan, Karthik, et al.
Publicado: (2022) -
Extensive cardiac FDG uptake in a patient with AL amyloidosis
por: Hatipoglu, Suzan, et al.
Publicado: (2023) -
P-130: The impact of COVID-19 on the treatment regimens of myeloma and AL amyloidosis patients
por: Joyner, Katie, et al.
Publicado: (2021) -
Therapeutic Outcomes in High-Grade B-Cell Lymphoma, NOS: Retrospective Analysis
por: Karunakaran, Parathan, et al.
Publicado: (2022) -
AL Amyloidosis in a Patient with IgD Myeloma
por: Rafik, Hicham, et al.
Publicado: (2020)